The Mevalonate Pathway: a Rational Target To Enhance Efficacy of BH3 Mimetics in Blood Cancer

Tea will be served at 3:45 pm.

Audience

This program is open to the research community.

Date & Time(s)

Location

Memorial Sloan Kettering Cancer Center
1275 York Avenue
Room M-107
New York, NY 10065

Sponsor(s)

Molecular Pharmacology and Chemical Biology Program

Speaker(s)

David Fruman, PhD
Professor, Department of Molecular Biology & Biochemistry
Associate Director, Cancer Research Institute
University of California, Irvine
Irvine, CA